A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

NCT04825743 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2463

Enrollment

INDUSTRY

Sponsor class

Conditions

ST-elevation Myocardial Infarction (STEMI)

Interventions

DRUG: zalunfiban
DRUG: Placebo

Sponsor

CeleCor Therapeutics